MYCN and neoplasm: Similar results were observed in another transgenic mouse model with Cre-conditional induction of MYCN in dopamine β-hydroxylase-expressing cells termed LSL-MYCN/Dbh-iCre, where clinically relevant NB tumor development occurred in 75% of mice [37].